BONE BIOLOGICS CORP (BBLG)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.57+1.86%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BBLG
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | — | — | 1,070.0 | 1,070.0 | — | — | — | — | — | — | — | — |
| Total Revenues | — | — | — | — | — | — | 1,070.0 | 1,070.0 | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 0.9 | 1.1 | 2.1 | 6.9 | 1.6 | 0.1 | 0.3 | 1.1 | 0.1 | 1.4 | 10.2 | 3.7 | 0.6 | — | — | — |
| Operating Income | (3.1) | (3.2) | (4.2) | (9.4) | (3.7) | (1.1) | (0.8) | (2.4) | (2.8) | (2.6) | (20.4) | (12.0) | (3.0) | (0.0) | (0.0) | (0.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | 0.1 | — | 1.4 | — | — | — |
| Other Non-Operating Income / Expenses | 0.2 | 0.1 | 0.1 | 0.5 | 2.2 | (0.5) | (1.0) | (1.0) | (1.6) | (4.4) | (5.5) | (1.9) | (1.4) | — | — | — |
| EBT, Incl. Unusual Items | — | — | — | — | — | (1.6) | (1.8) | (3.4) | (4.4) | (7.0) | (25.9) | (13.9) | (4.4) | (0.0) | (0.0) | (0.0) |
| Income Tax Expense | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (2.9) | (3.1) | (4.1) | (8.9) | (1.5) | (1.6) | (1.8) | (3.4) | (4.4) | (7.1) | (25.9) | (13.9) | (4.4) | (0.0) | (0.0) | (0.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (1.61) | (2.65) | (4.83) | (34.01) | (31.15) | (0.35) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (1.61) | (2.65) | (4.83) | (34.01) | (31.15) | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 1.8 | 1.2 | 1.5 | 0.3 | 0.0 | — | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 1.8 | 1.2 | 1.5 | 0.3 | 0.0 | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBIT | (3.1) | (3.2) | (4.2) | (9.4) | (3.7) | (1.1) | (0.8) | (2.4) | (2.8) | (2.6) | (20.4) | (12.0) | (3.0) | (0.0) | (0.0) | (0.0) |
| Effective Tax Rate | — | — | — | — | — | -0.1% | -0.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.1% | -0.0% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.